Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11 SEK | +0.46% | +2.80% | -26.17% |
Sales 2024 * | 36M 3.46M | Sales 2025 * | 60M 5.76M | Capitalization | 236M 22.7M |
---|---|---|---|---|---|
Net income 2024 * | -11M -1.06M | Net income 2025 * | 20M 1.92M | EV / Sales 2024 * | 6.12 x |
Net cash position 2024 * | 16M 1.54M | Net cash position 2025 * | 30M 2.88M | EV / Sales 2025 * | 3.44 x |
P/E ratio 2024 * |
-22
x | P/E ratio 2025 * |
12.1
x | Employees | 13 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 45.17% |
1 day | +0.46% | ||
1 week | +2.80% | ||
Current month | -3.08% | ||
1 month | +5.26% | ||
3 months | -17.60% | ||
6 months | -18.22% | ||
Current year | -26.17% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 58 | 07-12-31 | |
Gunnar Tufveson
CTO | Chief Tech/Sci/R&D Officer | - | 17-12-31 |
Fredrik Carlsson
CTO | Chief Tech/Sci/R&D Officer | - | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Magnus Nilsson
BRD | Director/Board Member | 68 | 20-11-17 |
Director/Board Member | - | 04-12-31 | |
Chairman | 51 | 04-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 11 | +0.46% | 6,128 |
24-06-03 | 10.95 | -3.52% | 3,092 |
24-05-31 | 11.35 | -2.99% | 13,959 |
24-05-30 | 11.7 | +4.46% | 1,223 |
24-05-29 | 11.2 | +4.67% | 19,928 |
Delayed Quote Nasdaq Stockholm, June 04, 2024 at 08:26 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.17% | 22.59M | |
+14.45% | 9.15B | |
-13.94% | 4.9B | |
+48.58% | 4.46B | |
+14.10% | 4.09B | |
+19.66% | 2.49B | |
-25.55% | 2.17B | |
+18.39% | 2.1B | |
-39.57% | 1.89B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- CLBIO Stock